Efficacy and safety of hydromorphone for cancer pain: a systematic review and meta-analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hydromorphone effectively manages cancer pain, showing similar safety and efficacy to morphine and oxycodone. It offers a viable alternative for patients experiencing cancer-related pain, with comparable adverse events across different administration methods.
Area Of Science
- Oncology
- Pain Management
- Pharmacology
Background
- Opioid analgesics, particularly morphine, are standard for cancer pain but have adverse effects.
- Hydromorphone presents a potent alternative for managing cancer-related pain.
- This study systematically reviews hydromorphone's efficacy and safety against other opioids and administration methods.
Approach
- A systematic review and meta-analysis adhering to PRISMA guidelines.
- Searched major databases (PubMed, Embase, Cochrane, Scopus, Web of Science) in December 2023.
- Utilized a random-effects model for meta-analyses based on PICO criteria.
Key Points
- Included 18 RCTs with 2271 patients comparing hydromorphone to morphine, oxycodone, or fentanyl.
- Hydromorphone demonstrated comparable pain reduction and quality of life improvements to morphine and oxycodone.
- Morphine showed a slight advantage in managing breakthrough cancer pain; adverse events were similar across opioids.
Conclusions
- Hydromorphone is an effective and safe option for cancer pain management, comparable to morphine and oxycodone.
- Findings support hydromorphone as a feasible alternative for cancer pain relief.
- Further research is recommended for specific patient groups and administration routes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...